Timing the initiation of treatment in Parkinson's disease

Grosset, Donald G.; Schapira, Anthony H.
June 2008
Journal of Neurology, Neurosurgery & Psychiatry;Jun2008, Vol. 79 Issue 6, p615
Academic Journal
The article presents views and insights of the author concerning the timing in the initiation of treatment in Parkinson's disease (PD). Clinical, imaging and pathological studies suggest that the cell loss begins 7 to 10 years before the onset of clinical features sufficient to allow the diagnosis of PD. The author also discusses the benefits of drug treatment of PD.


Related Articles

  • α-Adrenoceptor Antagonists: A New Approach to Parkinson's Disease? Brefel-Courbon, C.; Thalamas, C.; Saint Paul, H.P.; Senard, J-M.; Montastruc, J-L.; Rascol, O. // CNS Drugs;1998, Vol. 10 Issue 3, p189 

    Postmortem studies have shown that noradrenergic neurotransmission is impaired in Parkinson's disease. This abnormality may have functional importance because α-adrenoceptor antagonists, which increase central noradrenergic transmission, improve motor behaviour in various animal models of...

  • Parkinson's Disease Current Treatment. Wheaton, Jerry; Wright Jr., John M. // Officer Review Magazine;Nov2006, Vol. 46 Issue 4, p21 

    The article focuses on the current medications of Parkinson's disease, a degenerative disorder of the central nervous system characterized by tremor and impaired muscular coordination. Newer medications sustain the action of naturally produced dopamine by freezing the action of the enzyme that...

  • BEATING Parkinson's. Campbell, Annette; Gibson, Donna // Woman's Day (Australia Edition);4/18/2005, Vol. 57 Issue 16, p78 

    Provides information on Parkinson's disease. Cause of the disease; Manifestations of the disease; Available treatments; Relation of depression with Parkinsonism.

  • Verbal and visual memory in patients with early Parkinson's disease: Effect of levodopa. Singh, Sumit; Behari, Madhuri // Neurology India;Mar2006, Vol. 54 Issue 1, p33 

    Background: The effect of initiation of levodopa therapy on the memory functions in patients with Parkinson's disease remains poorly understood. Aims: To evaluate the effect of initiation of levodopa therapy on memory, in patients with early Parkinson's disease. Settings and Design: Prospective...

  • Should Parkinson's patients take CoQ10?  // Life Extension;2004 Collectors Edition, Vol. 10, p18 

    The article reports that Parkinson's disease is the second most common degenerative brain disorder. The percentage of the population afflicted by Parkinson's is on the rise. Researchers question why some people develop Parkinson's while others escape its clutches. One of the answers under...

  • Parkinson's's progression may be modified by new drug.  // Nursing Standard;6/16/2004, Vol. 18 Issue 40, p10 

    Focuses on the article "Rasagiline May Slow Progression of Parkinson's Disease," published in the 2004 issue of "The Pharmaceutical Journal."

  • New rescue drug cleared for Parkinson's 'off-periods'. Belden, Heidi // Drug Topics;5/17/2004, Vol. 148 Issue 10, p17 

    For patients with Parkinson's disease who experience episodes of hypomobility or off periods, in which they are often unable to get up out of a chair, walk, or even talk, there may be some relief in sight. Designated an orphan drug, the apomorphine hypochloride was granted, as of May 2004,...

  • The treatment of patients with Parkinson's desease: who cares? de Yébenes, Justo García // Practical Neurology;Apr2005, Vol. 5 Issue 2, p66 

    This article focuses on the treatment of patients with Parkinson's disease. The disease is the second most common neurodegenerative disorder in developed countries, after Alzheimer's disease, with an estimated prevalence of three patients per 1000 population. The treatment of patients with...

  • Taste responses in patients with Parkinson's disease. Sienkiewicz-Jarosz, H.; Scinska, A.; Kuran, W.; Ryglewicz, D.; Rogowski, A.; Wrobel, E.; Korkosz, A.; Kukwa, A.; Koslowski, W.; Bienkowski, P. // Journal of Neurology, Neurosurgery & Psychiatry;Jan2005, Vol. 76 Issue 1, p40 

    Objective: Predinical studies indicate that dopaminergic transmission in the basal ganglia may be involved in processing of both pleasant and unpleasant stimuli. Given this, the aim of the present study was to assess taste responses to sweet, bitter, sour, and sally substances in patients with...


Read the Article


Sign out of this library

Other Topics